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Abstract
Objective: Kidney transplantation can be associated with 
complications encountered during or after operation. Graft survival 
and immunosuppressant drugs have improved the outcome of 
transplantation, but infection of grafts have become a leading concern. 
The diagnosis of infection in such patients is challenging due to the 
lack of the typical infection indicators like fever since the patients are 
immunocompromised. This study investigates the extent of infection in 
transplanted patients, and it will look into the type of microorganisms 
encountered, their management and outcome. 
Methods & Materials: A retrospective study was carried out between 
the periods of 1st of January 2004 and 31st of December 2014. All 
renal transplant patients admitted during this period were investigated 
according to the reason of admission, and only those with suspected 
infection were enrolled.
Results: A total of 108 patients included based on suspicion of 
infection after renal transplant. Some of the patients had recurrent 
history of infectious over the 10-year period. Out of the 108 patients, 
74 received transplant from living donors (68.52%). The diagnosis on 
admission was limited to certain signs and symptoms. Urinary tract 
infections were suspected in 35.19% of the patients, and pneumonia 
was diagnosed in 10.19% of the patients. The majority of patient 
(89.96%) were on maintenance dose of steroids, and were followed 
by mycophenolate mofetil (MMF), tacrolimus and cyclosporine with a 
percentage of 81.48%, 46.3% and 25.93%, respectively. Regarding 
antibiotics, 86.11% of the admitted patient were started on single 
antibiotic on admission including those with recurrent admission.
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Introduction 
Kidney transplantation is the process of trans-
planting the organ to a patient with end stage renal 
disease and its subdivided according to the donor 
type. It is indicated in all end stage renal disease 
patients regardless of the cause. 
The first kidney transplant was done in the 
United States in the 1950 which failed few months 
later due to lack of immunosuppressant medica-
tion. Other attempts followed in France and United 
Kingdom in 1952 and 1960, respectively [1]. 
Complications with transplant can be encoun-
tered during and after a varying period of opera-
tion. It includes graft failure, infection, bleeding and 
thrombosis. Infections are induced due to the immu-
nosuppressant medication given to the transplant 
recipient. They are occurring most commonly in the 
mucocutanous areas (41%), urinary tract (17%) and 
the respiratory tract (14%). The most common infec-
tious agents are bacterial (46%), viral (41%), fungal 
(13%), and protozoan(1%). The most common viral 
agents are cytomegalovirus (31.5%), herpes simplex 
(23.4%), and herpes zoster (23.4%) [2]. 
Infection of grafts represent a leading concern. It 
is becoming the main reason for admission through 
accident and emergency department of transplant 
patients. Due to the various types of immunosup-
pressant medications being used a group of patho-
gens like BK virus and cytomegalovirus which were 
rarely diagnosed and are being seen more frequent-
ly in the post transplant period.
The diagnosis of infection in transplant patients is 
challenging due to the lack of the typical infection 
indicators like fever as these patients are immuno-
compromised. Another challenge is once the source 
of infection is identified, the physician must alter 
the immunosuppressant medication to maintain a 
balance between controlling the causative patho-
gen and not to lose the graft function. Therefore, 
antibiotics must be carefully selected as many are 
nephrotoxic.
In Kingdom of Bahrain, Salmaniya Medical Com-
plex is the only hospital carrying the kidney trans-
plant procedures. A local transplant team was es-
tablished in the hospital in 1995 and since then 
there is a continuous work to improve the transplant 
services. The objective of our study is to study the 
spectrum of infection observed in the transplanted 
patients. The study aimed to investigate the pattern 
of microorganisms encountered, their management 
and outcome as well as to abstract recommenda-
tion to control infection in renal transplant patients.. 
Patients and Materials 
This 10-year retrospective study was carried out 
over the periods of 1st of January 2004 and 31st of 
December 2014. All renal transplant patients admit-
Conclusion: Fever is a common presenting symptom in our population 
of transplant recipients which reflects the possibility of infection. The 
majority responded to a single antibiotic tratment. 
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ted during this period were segregated according to 
the reason of admission. Only those with impres-
sion of infection were enrolled. The end result was 
of 192 patients who had this impression, however, 
only the records of 108 patients were found and 
finally enrolled in the study. 
The data of the patients were collected on a writ-
ten form prepared by the research team. The data 
included general biographic information, type of 
infection, type of antibiotics used, and occurrence 
of any complications, and finally the appearance of 
rejection and whether it is related to the infection.
Results 
A total of 108 patients were investigated over a 
10-year period who suspected to be infected after 
renal transplant. Some of the patients had recurrent 
history of suspected infection. The age of patients 
was ranged between 15 to 75 years old, of these 
57 were males and 34 were females. 
A total of 74 patients out of 108 patients, re-
ceived transplant from living donors (68.52%), six 
from cadavers (5.56%), and 27 (25%) the source 
of transplant couldn’t be verified in their medical 
records (Figure 1). A total of 26 patients out of 
74 received transplant from related donor, 31 from 
non-related and 17 the source of living donor was 
unknown in the medical records. All patients re-
ceived their organs between the periods of 1962 
and 2013, but only those who showed signs of 
infection within the period 2004 and 2014 were 
enrolled in the study.
The diagnosis of patients on admission was limit-
ed to certain differentials with an average period of 
weeks to few months after the transplant and the 
first infective episode. A total of 38 /108 (35.19%) 
patients were admitted with urinary tract infection 
(UTI), and 11/108 (10.19%) whom had history of 
recurrent UTI on several occasions. These had vari-
ous significant complains on admission as follow: 
dysuria 85.71%, fever 65.31%, abdominal or flank 
pain 24.49% and 10.20% with no symptoms but 
their routine urine culture grew positive organism 
[Figure 2]. The clinical assessment showed that only 
15 / 49 patients had documented fever above or 
equal to 38 o C, six with abdominal pain and the 
rest had normal results. The positive results of 38 
urine cultures are demonstrated in Figure 2. The 
majority of urine cultures were sterile in 33 patients 
(47.83%; single or multiple admissions), E. coli grew 
in 11 patients (15.94%) and ESBL-producing E. coli 
was detected in 16 patients( 23.19%) (Figure 2). 
Gastroenteritis was diagnosed in 28.70% of the 
patients. Stool culture however, was done only for 
22 / 31 patients and all were negative for enteric 
pathogens, except one case of Salmonella spp. 
Fever was presented in 16.67% patients, of these 
13/18 had fever above or equal to 38 o C. 
 Pneumonia was diagnosed in 11/108 patients 
(10.19%). The majority presented to the emergen-
cy with complain of fever, cough and shortness of 
breath. Three cases were diagnosed as tonsillitis. Chest 
x-ray on admission showed that 7 had lobar infiltrate, 
three normal x-ray and three bilateral infiltrate. The 
deep tracheal aspiration (DTA)/ sputum was negative 
for potential pathogens in 8 examined cases. Posi-
tive cultures grew the following: one Candida spp., 2 
methicilin-resistant S. aureus (MRSA), one Pseudomo-Figure 1. The type of kidney donors.
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nas spp., one multidrug resistance (MDR) Pseudomo-
nas spp., one ESBL-producing Klebsiella spp. 
Blood cultures done for 97 patients, and of 
these, 8 had positive cultures. Three cultures grew 
E. coli ESBL-producing, and each of the following 
grew one isolate of MDR Pseudomonas spp., E. coli, 
MDR Acinetobacter spp., Pseudomonas spp. and 
Enterobacter spp.
Cytomegalovirus serology test (IgM, IgG) was 
done for 76 patients. Two out the 76 patients were 
IgM positive, 16 were positive for IgG, and the rest 
were negative for both types. Those who were posi-
tive for the IgG, the viral load was done for only 
five of them and it was negative in these patients. 
All patients were treated with multiple immunosup-
pressants as shown in Figure 3. 
Regarding the antibiotics, 86.11% of the admit-
ted patient were started on single antibiotic on ad-
mission including those with recurrent admission, 
whereas 47.11% were on multiple antibiotics either 
as an overlap or at different timing. Ceftriaxone was 
the main antimicrobial to be prescribed as a single 
agent (56.5%) followed by Meropenem (19.4%) and 
Pipracillin-Tazobactam (4.6%). Five patients(24.1%) 
were on metronidazole combined with the other 
antimicrobials. It was prescribed to all patients who 
had gastrointestinal symptoms and a case of facial 
cellulitis. Only two patients were treated with an-
tifungal (one with flucanazole and the other with 
voriconazole). Cotrimaxazole, azithromycin, colistin 
and lLinezolid were prescribed for different patients 
in combination with other agents. Six of the pa-
tients needed invasive ventilation due to deteriora-
tion in their general condition. Total seven patients 
were shifted to the intensive care unit. Two of them 
were shifted back to the ward after the condition 
stabilized and five died. The cause of death accord-
ing to the death certificate was three septic shock, 
one cardiogenic shock and one case cardiorenal 
failure. Another in-patient diagnosed to have viral 
meningitis in addition to his urinary tract infection 
and acyclovir was added to his anti-microbial. 
None of the patients needed any surgical inter-
vention during their stay except for who underwent 
ERCP as he was admitted with deranged liver func-
tion test, jaundice and urinary tract infection. Fortu-
nately, during the episode of infection none of the 
patients developed an acute rejection. 
Figure 2. Urine culture results.
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Discussion 
The renal transplant patients are normally sus-
ceptible to infection with a wide range of organisms 
since they are immunosuppressant [3]. Common ex-
posures to infection in the community are often 
related to contaminated food and drinks, contact 
with infected family members or coworkers and 
others. In addition, they acquire commonly nosoco-
mial infections especially with MDR organisms such 
as MRSA and ESBL-producing bacteria during their 
regular hospital visits for clinic follow up. 
This study demonstrates that many of our pa-
tients have recurrent hospital admissions due to sign 
or symptom of infection such as fever, urinary or 
respiratory symptoms. Many studies showed that 
UTI is the major reason of infection in transplant pa-
tients [4]. Our study found that 35% of the patients 
had uncomplicated course of UTIs, and they were 
recovered mostly after treatment with ceftriaxone. 
Mitra et al., (2011 ) found that female transplant 
recipients had significantly more UTIs than males, 
and the majority of the organisms were Gram-neg-
ative bacilli with E.coli is being the most common 
bacterial type [4]. Since these patients have high 
incidence of asymptomatic UTIs, it is recommend-
ed to give them antibiotic prophylaxis for a period 
ranging from 6-12 months. The recommended anti-
microbial drugs are ciprofloxacin and trimethoprim-
sulfamethoxazole [5]. 
Gastroenteritis or diarrhea is also common mani-
festations among transplant patients. The majority 
of cases are mild and self limited attack. Prolonged 
cases can compromise the transplanted kidney by 
severe dehydration. It is argued that some of the 
diarrheal episodes are drug related rather than due 
to infectious agent. 
This study demonstrated that the third reason 
for admission was gastroenteritis associated with 
diarrhea as main symptom. Upon investigations, all 
stool cultures were negative for pathogens but the 
patients were treated for infective diarrhea with a 
single antibiotic, mostly ceftriaxone and all of the 
patients showed a good response without any 
changes in the immunosuppressant medication. 
 An open nonrandomized, multicenter study done 
in Belgium during 2006, has reported similar results 
to our findings about diarrhea, it has identify ap-
Figure 3. The number of transplant patients on Immunosuppressant.
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proximately 50% of patients experienced resolution 
of severe diarrhea following treatment for infections, 
or diarrhea associated with medications or due to 
dietary factors. The study concluded that a large 
proportion of the severe diarrhea observed in renal 
transplant recipients is not associated with immuno-
suppressive therapy and can be treated with anti-
infective drugs and other empirical treatments [6]. 
Fungal infections are opportunistic infections that 
are rarely cause an infection in immune-competent 
persons. However, the transplant patients are suscep-
tible candidates for such organisms. Organism like 
Pneumocystis cranii (PCP) and Aspergillus spp. can 
result in mortality up to 68% in immunosupressed 
transplant recipients [7]. A multinational case-control 
study in Europe which included 19 institutions and 
carried out between 2000 and 2013, has reported 
that 51 kidney transplant recipients were diagnosed 
to have invasive pulmonary aspergillosis (IPA) after 
a period of 180 transplant days. Controls recipients 
were matched by center and date of transplanta-
tion, and overall mortality among cases was 60.8% 
and 25.0% and survivors experienced graft loss. 
Additionally, the study showed that pre-transplant 
diagnosis of chronic pulmonary obstructive disease 
(COPD) and delayed graft function were identified 
as risk factors for IPA. The development of blood-
stream infection and acute graft rejection within 
the three months prior to the diagnosis of IPA was 
also risk factors during the subsequent period [8]. 
The present study has not detected any fungal in-
fection among our patients, and this reflects good 
patient infection control protocols in the hospital 
and home setting to prevent airborne or person to 
person transmission of infection plus proper PCP 
prophylaxis after transplantation. 
Renal transplant recipients who are immunosu-
preseed are susceptible also for viral infections. BK 
virus is ubiquitous among general population, re-
main dormant in healthy persons, and studies had 
showed positive serum prevalence around 80% fol-
lowing an asymptomatic primary infection. BK virus 
becomes active mainly among patients who have 
received a kidney transplant, in whom the virus can 
cause tubulo-interstitial nephritis and result in graft 
failure among approximately 20 to 30% of nephritic 
cases [9]. In addition, approximately 1% to 5% of 
transplant patient may develop allogenic nephropa-
thy due to infection with BK virus which can be 
detected via serum and urine assays. Antivirals are 
available to treat such viral infection but they can 
be managed only with immune-suppressant dose 
reduction [10]. 
Cytomegalovirus (CMV) is a common cause of 
mortality and morbidity among transplant popula-
tion with symptomatic infections are seen in 20% 
to 60%. Infection of CMV can be observed directly 
after discontinuing the prophylactic medication by 
developing fever, arthritis, hepatitis, meningitis and 
myalgia or indirect effect through graft rejection, 
and the virus can be treated successfully by oral and 
intravenous medications[11]. 
The present study has not detected any patient 
with viral infection, except a single patient which 
has developed viral meningitis and he was treated 
with acyclovir successfully assuming it had herpes 
simplex infection. 
In conclusion, fever is a common presenting symp-
tom in our examined transplant recipients, and this 
feature reflects the possibility of microbial infection. 
The majority responded to a single antibiotic use, 
and none of them had any of the virulent oppor-
tunistic infection. The limitation of our study is the 
small number of examined transplanted patients. 
Currently, we recommend to continue applying the 
same prophylaxis and management protocol for the 
transplant patients in our center. 
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